Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $71.07 | $17.62 | 303.24% | 296.13x | 20.81x | 21.71x | 58.21x | 1.46x | $41.15M | 0.66% | $108.58M | 1.23 | $6.28B | 117.21 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.91 | $20.71 | 285.88% | 173.72x | 152.62x | 10.85x | 13.45x | 1.47x | $119.79M | 1.44% | $637.99M | 6.11 | $8.48B | -1,234.98 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.95 | $2.92 | 138.09% | 99.29x | 64.89x | 3.76x | 92.22x | 0.91x | $47.52M | 4.01% | $13.01M | 0.08 | $1.35B | 25.20 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $278.09 | $93.34 | 197.94% | 63.78x | 36.87x | 8.62x | 34.53x | 1.32x | $641.34M | 1.74% | $1.08B | 8.09 | $38.39B | 41.52 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $55.11 | $17.29 | 218.77% | 56.23x | 43.17x | 5.59x | 7.00x | 1.52x | $164.23M | 3.89% | $605.69M | 7.92 | $4.06B | 36.41 | ||
| KRYS | KRYSTAL BIOTECH INC | $348.06 | $95.20 | 265.60% | 44.91x | 43.78x | 24.43x | 8.04x | 2.14x | $237.38M | 2.33% | $1.28B | 43.59 | $9.77B | 45.66 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.55 | $71.20 | -3.73% | 23.16x | 8.27x | 5.37x | 37.02x | 0.41x | $667.65M | 8.24% | $219.64M | 1.86 | $9.96B | 15.97 | ||
| VCEL | VERICEL CORP | $40.10 | $9.12 | 339.74% | 93.26x | 83.18x | 6.97x | 5.75x | 1.96x | $47.49M | 2.33% | $356.23M | 7.02 | $2.03B | 50.30 | ||
| ASND | ASCENDIS PHARMA A | $230.83 | $80.54 | 186.60% | 24.47x | 15.48x | 14.08x | 24.97x | 2.50x | $52.94M | 0.37% | $574.09M | 9.24 | $14.72B | 157.83 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.69 | $41.70 | 31.15% | 39.06x | 14.42x | 3.25x | 1.70x | 0.53x | $767.06M | 7.29% | $6.21B | 32.27 | $8.93B | 18.51 | ||
| RPRX | ROYALTY PHARMA PLC | $52.96 | $39.81 | 33.04% | 27.73x | 9.93x | 9.48x | 3.07x | 0.60x | $2.34B | 10.12% | $9.94B | 22.75 | $38.87B | 33.41 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.90 | $15.94 | -19.05% | 6.29x | 26.91x | 6.16x | 3.71x | 0.84x | $56.42M | 7.49% | $205.80M | 3.52 | $668.14M | 4.62 | ||
| ADMA | ADMA BIOLOGICS INC | $8.31 | $9.67 | -14.07% | 12.04x | 9.09x | 3.85x | 4.93x | 0.46x | $107.90M | 5.50% | $390.33M | 1.65 | $1.99B | 8.96 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $224.66 | $49.31 | 355.64% | 478.00x | 8.73x | 3.13x | 3.11x | 1.61x | $1.30B | 9.33% | $4.53B | 73.22 | $17.65B | 26.15 | ||
| TECH | BIO-TECHNE CORP | $57.94 | $15.29 | 278.95% | 81.61x | 29.53x | 7.48x | 4.35x | 1.68x | $269.60M | 2.98% | $2.09B | 13.34 | $9.15B | 35.75 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $274.88 | $94.20 | 191.79% | 34.79x | 30.29x | 19.91x | 5.52x | 1.75x | $122.22M | 2.24% | $997.32M | 50.16 | $5.85B | 25.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.28 | $35.68 | -6.72% | 13.15x | 9.04x | 2.14x | 2.12x | 0.50x | $341.79M | 17.76% | $910.35M | 15.75 | $1.50B | 6.31 | ||
| TGTX | TG THERAPEUTICS INC | $53.22 | $17.00 | 213.02% | 16.53x | 38.05x | 10.98x | 13.97x | 261.90x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.46B | 56.37 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.28 | $5.72 | -60.17% | 8.44x | 3.34x | 2.13x | 2.49x | 0.18x | $7.24M | 5.53% | $52.93M | 0.92 | $78.36M | 5.06 | ||
| EXEL | EXELIXIS INC | $51.91 | $30.78 | 68.62% | 16.64x | 15.76x | 5.64x | 6.74x | 1.21x | $917.69M | 6.84% | $1.94B | 7.49 | $12.99B | 12.30 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $451.63 | $167.60 | 169.46% | 26.55x | 23.10x | 9.39x | 5.92x | 1.94x | $3.71B | 3.23% | $19.36B | 76.20 | $111.12B | 20.60 | ||
| UTHR | UNITED THERAPEUTICS CORP | $536.59 | $242.77 | 121.03% | 18.33x | 18.86x | 7.36x | 3.86x | 2.03x | $1.02B | 4.36% | $5.90B | 135.66 | $21.50B | 12.55 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.50 | $2.45 | 42.58% | 14.58x | 14.79x | 2.14x | 3.39x | 0.98x | $4.11M | 1.46% | $82.33M | 1.03 | $214.78M | 10.11 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.38 | $12.22 | 156.72% | 17.34x | 16.00x | 6.43x | 3.79x | 3.89x | $208.13M | 5.42% | $1.01B | 8.28 | $3.09B | 9.22 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $609.94 | $435.14 | 40.17% | 14.33x | 12.96x | 4.25x | 2.03x | 0.97x | $4.11B | 6.48% | $31.42B | 302.15 | $63.69B | 11.09 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.22 | $1.26 | 76.51% | 11.68x | 10.22x | 2.32x | 2.66x | 2.88x | $13.00M | 7.34% | $67.23M | 0.84 | $145.64M | 6.52 | ||
| INCY | INCYTE CORP | $98.22 | $66.73 | 47.19% | 13.47x | 12.54x | 3.65x | 3.49x | 1.16x | $1.45B | 7.41% | $5.62B | 28.21 | $16.19B | 8.66 | ||
| VCYT | VERACYTE INC | $53.63 | $7.59 | 607.02% | 48.32x | 48.09x | 7.87x | 3.18x | 10.29x | $155.34M | 3.64% | $1.34B | 16.90 | $4.05B | 35.24 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.53 | $3.60 | 386.93% | 29.22x | 4.78x | 0.84x | 1.23x | 13.22x | $109.24M | 5.93% | $1.51B | 14.34 | $2.42B | 29.29 | ||
| MDXG | MIMEDX GROUP INC | $3.67 | $1.25 | 193.02% | 17.48x | -43.59x | 1.40x | 2.25x | 8.31x | $69.36M | 12.72% | $242.94M | 1.64 | $404.45M | 7.42 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.